Syndax Pharma (SNDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -140,463 | -72,400 | -209,360 | -136,887 | -85,741 |
| Depreciation Amortization | -7,464 | -3,818 | -14,791 | -11,335 | -7,679 |
| Accounts receivable | -9,582 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,607 | -1,152 | 5,611 | 1,699 | 6,629 |
| Other Working Capital | -26,547 | -10,400 | 31,860 | 5,850 | 4,259 |
| Other Operating Activity | 27,256 | 4,222 | 26,079 | 21,421 | 7,933 |
| Operating Cash Flow | $-155,193 | $-83,548 | $-160,601 | $-119,252 | $-74,599 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -37,649 | -99,399 | 117,609 | 133,899 | 93,822 |
| Investing Cash Flow | $-37,649 | $-99,399 | $117,609 | $133,899 | $93,822 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,844 | 2,168 | 264,132 | 5,649 | 3,798 |
| Financing Cash Flow | $2,844 | $2,168 | $264,132 | $5,649 | $3,798 |
| Beginning Cash Position | 295,611 | 295,611 | 74,471 | 74,471 | 74,471 |
| End Cash Position | 105,613 | 114,832 | 295,611 | 94,767 | 97,492 |
| Net Cash Flow | $-189,998 | $-180,779 | $221,140 | $20,296 | $23,021 |
| Free Cash Flow | |||||
| Operating Cash Flow | -155,193 | -83,548 | -160,601 | -119,252 | -74,599 |
| Free Cash Flow | -155,193 | -83,548 | -160,601 | -119,252 | -74,599 |